REG - Chrysalis Investment - Consultation Process Update

Chrysalis InvestmentsAnnouncement

Yesterday 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251104:nRSD0086Ga&default-theme=true

RNS Number : 0086G  Chrysalis Investments Limited  04 November 2025

The information contained in this announcement is restricted and is not for
publication, release or distribution in the United States of America, any
member state of the European Economic Area (other than to professional
investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the
Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of
South Africa.

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014 which forms part of domestic law in the United Kingdom
pursuant to The European Union Withdrawal Act 2018, as amended by The Market
Abuse (Amendment) (EU Exit) Regulations 2019.

 

4 November 2025

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

Consultation Process Update

 

In May 2025, the Board issued a Capital Allocation Update statement, which
included a commitment to undertake an independent shareholder consultation
exercise led by Rothschild & Co. Following engagement with shareholders
representing approximately 58% of the Company's voting rights, Rothschild
& Co has presented its findings to the Board. The Board would like to
thank all those shareholders who contributed to the consultation, which
covered a variety of topics including the Capital Allocation Policy ("CAP"),
structural options such as dual share class structures, governance/Board
composition, the investment advisory team and investment strategy.

 

There was widespread agreement that the Company's portfolio includes
attractive investments with significant inherent value. A significant
proportion of the shareholders consulted felt that Chrysalis should continue
to be structured and managed on a basis which affords appropriate scope for
these assets to achieve their full potential over time. However, it is clear
that a proportion of shareholders consulted are seeking an orderly exit from
their investment in a shorter timeframe.

 

The Board, together with its advisers has now, therefore, commenced a detailed
consideration of how best to evolve Chrysalis in response to the divergent
shareholder views. It is the Board's intention to analyse in detail the key
options for the future of the Company, while maintaining its dialogue with
shareholders, including the Investment Adviser (which did not form part of
Rothschild & Co's consultation process) with a view to publishing the
Board's favoured proposal with the annual results due to be published in
December 2025.

 

The Board highlights the following to shareholders on capital allocation:

 

·    No new investments will be made prior to the AGM in 2026.

·    The current programme of share buybacks will continue to complete the
return of up to £100 million - the second element of the CAP - which is
anticipated to be fulfilled during November 2025.

·    The Board will then continue the buyback programme to return at least
25% of profits from realised investments, to satisfy the third element of the
existing CAP.

·    The Board is satisfied that there will be sufficient capital
available under the current CAP for share buybacks in line with current
deployment levels to be continued until the AGM in March 2026.

 

 

-ENDS-

 

 For further information, please contact:

 Media                                             +44 (0) 7921 881 800

 Montfort Communications:                          chrysalis@montfort.london (mailto:chrysalis@montfort.london)

 Charlotte McMullen / Imogen Saunders

 Investment Adviser                                +44 (0) 20 7871 5343

 Chrysalis Investment Partners LLP:

 James Simpson

 AIFM                                              +44 (0) 20 7397 5450

 G10 Capital Limited:

 Maria Baldwin

 Deutsche Numis:                                   +44 (0) 20 7260 1000

 Nathan Brown / Matt Goss

 Panmure Liberum:                                  +44 (0) 20 3100 2222

 Chris Clarke / Darren Vickers

 Barclays Bank PLC:                                +44 (0) 20 7623 2323

 Dion Di Miceli / Stuart Muress / James Atkinson

 IQEQ Fund Services (Guernsey) Limited:            +44 (0) 1481 231 852

 Aimee Gontier / Elaine Smeja

 

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at
https://www.chrysalisinvestments.co.uk
(https://www.chrysalisinvestments.co.uk)

The information contained in this announcement regarding the Company's
investments has been provided by the relevant underlying portfolio company and
has not been independently verified by the Company. The information contained
herein is unaudited.

This announcement is for information purposes only and is not an offer to
invest. All investments are subject to risk. Past performance is no guarantee
of future returns. Prospective investors are advised to seek expert legal,
financial, tax and other professional advice before making any investment
decision. The value of investments may fluctuate. Results achieved in the past
are no guarantee of future results. Neither the content of the Company's
website, nor the content on any website accessible from hyperlinks on its
website for any other website, is incorporated into, or forms part of, this
announcement

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDGZMGMLFRGKZM



            Copyright 2019 Regulatory News Service, all rights reserved